St. Louis Joint Replacement Institute
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, St. Louis Joint Replacement Institute sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,751 sponsors by registered trial count).
St. Louis Joint Replacement Institute: 3 sponsored US clinical trials, none currently recruiting.
St. Louis Joint Replacement Institute sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is This Study Will Evaluate Whether TXA Reduces Pain, with 1 trials.
Upper-quartile sponsor footprint
St. Louis Joint Replacement Institute sits in the upper quartile of the sponsor corpus (#3,661 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
S-32 PG 242 Short Stem
NCT05083728
Effect of Tranexamic Acid (TXA) Administered Prior to Shoulder Arthroscopy on Postoperative Pain Medication Usage: A Randomized Controlled Trial
NCT06920264
Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery
NCT00474773
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
How the St. Louis Joint Replacement Institute early-phase archive is shaped
3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: This Study Will Evaluate Whether TXA Reduces Pain (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.